CUSIP 45674E109COMINABQ3 2025
17 filings · latest Dec 29, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bios Capital Management, LP | 286.7K | $622.1K |
| 4 | May 8, 2025 | Bios Fund II, LP | 13D/A | 10.0% | — | SEC |
| 5 | Feb 14, 2025 | William Tai-Wei Ho | 13G/A | 5.6% | 4.10M | SEC |
| 6 | Feb 14, 2025 | Alyeska Investment Group, L.P. | 13G | 9.9% | 7.24M | SEC |
| 7 | Jan 31, 2025 | Orin Hirschman | 13G/A | 8.5% | 619.19T | SEC |
| 8 | Oct 11, 2024 | Bios Fund II, LP | 13D/A | 0.8% | 574.4K | SEC |
| 9 | Oct 9, 2024 | Hirschman Orin | 13G | 9.3% | 6.74M | SEC |
| 10 | Sep 17, 2024 | Hirschman Orin | 13G/A | 5.0% | 2.33M | SEC |
See the full Schedule 13D/13G history for In8bio Inc.
Unlock full history